Insider Shareholders with Direct Ownership of Onconova Therapeutics, Inc. (ONTX)
This section provides a comprehensive overview of the insiders with direct ownership of Onconova Therapeutics, Inc. (ONTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Onconova Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Armistice Capital, Llc
> 10% Shareholder |
0 | 10,249 | 816,702 $481,854 | 1 |
Sep 23, 2019
Reduced 1.24%
|
|
Werner Cautreels
Chief Executive Officer |
200,000 | 0 | 200,000 $118,000 | 1 |
Apr 01, 2024
Added 50.0%
|
|
Charles David Pauza
Chief Science Officer Virology |
97,500 | 0 | 97,500 $57,525 | 1 |
Apr 01, 2024
Added 50.0%
|
|
Robert Redfield
Acting Chief Medical Officer |
97,500 | 0 | 97,500 $57,525 | 1 |
Apr 01, 2024
Added 50.0%
|
|
Steven M Fruchtman
PRESIDENT, CHIEF EXECUTIVE OFF |
153,265 | 34,222 | 74,792 $44,127 | 13 |
Mar 14, 2024
Reduced 10.45%
|
| 50,735 | 0 | 50,735 $29,933 | 2 |
Feb 16, 2021
Added 20.4%
|
|
| 79,335 | 13,392 | 39,255 $23,160 | 17 |
Jun 18, 2024
Reduced 5.35%
|
|
|
Abraham N. Oler
SVP Corp Dev & Gen Counsel |
76,381 | 0 | 24,514 $14,463 | 10 |
Jan 28, 2022
Added 5.77%
|
| 69,726 | 0 | 21,334 $12,587 | 3 |
Sep 28, 2021
Added 21.81%
|
|
|
Mark S. Md Gelder
CHIEF MEDICAL OFFICER |
12,864 | 2,377 | 10,487 $6,187 | 5 |
Feb 07, 2023
Reduced 10.59%
|
|
Iain D. Dukes
Executive Chairman |
134,237 | 0 | 0 $0 | 1 |
N/A
|
|
Nikolay Savchuk
Chief Operating Officer |
134,237 | 0 | 0 $0 | 1 |
N/A
|